Literature DB >> 10386196

A rapid-cycling bipolar patient treated with long nights, bedrest, and light.

A Wirz-Justice1, C Quinto, C Cajochen, E Werth, C Hock.   

Abstract

BACKGROUND: Stabilization of rapid-cycling bipolar disorder is extremely difficult.
METHODS: A refractory bipolar I rapid-cycling patient on valproate was treated with long "nights" (extended sleep in darkness) and daytime light therapy.
RESULTS: Rapid cycling immediately stopped on initiation of a 10 hour dark/rest period. This was extended to 14 hours (plus a self-selected 1 hour midday nap) without problems. Depression gradually improved when midday light therapy was added; near-euthymia was attained after light therapy was shifted to the morning.
CONCLUSIONS: Nonpharmacological chronobiological treatments may be a means to interrupt rapid cycling.

Entities:  

Mesh:

Year:  1999        PMID: 10386196     DOI: 10.1016/s0006-3223(98)00289-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  Sleep and Circadian Rhythm Disorder in Bipolar Affective Disorder.

Authors:  Attia Ahmad; Kirstie N Anderson; Stuart Watson
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 2.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 3.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

4.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

Review 5.  Rapid cycling bipolar disease: new concepts and treatments.

Authors:  S L Dubovsky
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

6.  Spectrophotometric properties of commercially available blue blockers across multiple lighting conditions.

Authors:  Brooke J Mason; Andrew S Tubbs; Fabian-Xosé Fernandez; Michael A Grandner
Journal:  Chronobiol Int       Date:  2022-01-04       Impact factor: 3.749

7.  Chronobiology and mood disorders.

Authors:  Anna Wirz-Justice
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

8.  Light treatment of mood disorders.

Authors:  Barbara L Parry; Eva L Maurer
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

9.  Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial.

Authors:  Tone Eg Henriksen; Silje Skrede; Ole B Fasmer; Helle Schoeyen; Ieva Leskauskaite; Jeanette Bjørke-Bertheussen; Jörg Assmus; Børge Hamre; Janne Grønli; Anders Lund
Journal:  Bipolar Disord       Date:  2016-05       Impact factor: 6.744

10.  The evening light environment in hospitals can be designed to produce less disruptive effects on the circadian system and improve sleep.

Authors:  Daniel Vethe; Jan Scott; Morten Engstrøm; Øyvind Salvesen; Trond Sand; Alexander Olsen; Gunnar Morken; Hanne S Heglum; Kaia Kjørstad; Patrick M Faaland; Cecilie L Vestergaard; Knut Langsrud; Håvard Kallestad
Journal:  Sleep       Date:  2021-03-12       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.